NCT06070103

Brief Summary

  1. 1.Assessment the prevalence of psychiatric disorders in diabetic patient in Assuit University Hospital.
  2. 2.Determine the associated factors with the psychiatric disorders.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
325

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2024

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 30, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 6, 2023

Completed
6 months until next milestone

Study Start

First participant enrolled

April 1, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

February 28, 2024

Status Verified

February 1, 2024

Enrollment Period

8 months

First QC Date

September 30, 2023

Last Update Submit

February 26, 2024

Conditions

Keywords

depressionanxietystress

Outcome Measures

Primary Outcomes (1)

  • Depression ,Anxiety and stress disorders among diabetic patients in Assuit University Hospitals.

    1. Assessment the prevalence of psychiatric disorders in diabetic patient in Assuit University Hospital. 2. Determine the associated factors with the psychiatric disorders.

    Baseline

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Type 1 diabetes is a lifelong autoimmune disease characterized by insulin deficiency and resultant hyperglycemia. It constitutes around 10% of all diagnosed cases of diabetes and its incidence is increasing globally. Type 2 diabetes mellitus (DM2) is a chronic metabolic disease characterized by an increase in normal serum glucose levels (hyperglycemia).

You may qualify if:

  • Age between 18 and 70 years Diagnosed according to criteria of the American Diabetes Association fasting plasma glucose (FPG) level of 126 mg/dL (7.0 mmol/L) or higher or A 2-hour plasma glucose level of 200 mg/dL (11.1 mmol/L) or higher during a 75-g oral glucose tolerance test (OGTT).

You may not qualify if:

  • Patient with cognitive difficulties
  • To be very sick and unable to give consent
  • Women who were pregnant or had given birth in the last 6 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Diabetes MellitusDepressionAnxiety Disorders

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesBehavioral SymptomsBehaviorMental Disorders

Central Study Contacts

Alaa ab mohamed, master

CONTACT

Dalia G Mahran, Professor

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
resident doctor

Study Record Dates

First Submitted

September 30, 2023

First Posted

October 6, 2023

Study Start

April 1, 2024

Primary Completion

November 30, 2024

Study Completion

December 31, 2024

Last Updated

February 28, 2024

Record last verified: 2024-02